Nicholas J. Linker, MD, FRCP, FESC

A Prospective, Randomized Trial to Determine the Early and
Late Reactions After the Use of Iopamidol 340 (Niopam‚Ñ¢)
and Iobitri

08/01/2008

James A. Hall , MA, MD, FRCP;

David O. Williams , MD, PhD;

Nicholas J. Linker , MD, FRCP, FESC;

Michael J. Stewart , MD, FRCP;

Adrian Davies , BSc, MB, FRCP;

Alun A. Harcombe , MD, MRCP;

Mark A. de Belder , MA, MD, FRCP;

Kunadian Vijayalakshmi , MBBS, MRCP;

Intravascular contrast is a prerequisite for modern invasive cardiology. The contrast agents used for various procedures have become increasingly safe in recent years. Compared to ionic agents, the modern non-ionic contrast agents are fairly...

Intravascular contrast is a...

08/01/2008

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 7 ⁠–⁠ November 10

November 8 ⁠–⁠ November 10

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

See Full Calendar

Nicholas J. Linker, MD, FRCP, FESC

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products